# Neurophysiological Characteristics of Upper Extremity Neuropathy in Three Young Patients with Mucopolysaccharidosis Type I and II in a Five-Year Observation—A Case Series Study

**Authors:** Agnieszka Wiertel-Krawczuk, Zofia Krawczuk, Juliusz Huber

PMC · DOI: 10.3390/neurolint18020032 · Neurology International · 2026-02-11

## TL;DR

This study tracks nerve changes in three young MPS patients over five years, showing progressive nerve damage and suggesting early neurophysiological testing could improve treatment outcomes.

## Contribution

The study provides new insights into the progression of peripheral neuropathy in MPS patients through longitudinal neurophysiological assessments.

## Key findings

- Decreased amplitudes and prolonged distal latencies in CMAP recordings indicate axonal degeneration and demyelination in median nerves.
- Sensory fibers of the median nerves showed more severe degenerative changes compared to motor fibers.
- Ulnar nerve pathologies were present but less severe than those in the median nerves.

## Abstract

Background/Objectives: To date, few studies have reported the use of neurophysiological testing to assess the long-term progression of functional changes in median and ulnar nerve conduction in children and adolescents with mucopolysaccharidosis (MPS). This case series study aimed to perform an electroneurographic (ENG) assessment of the median and ulnar nerves in three young patients with MPS treated with enzyme replacement therapy (ERT) and hematopoietic stem cell transplantation (HSCT) over a five-year observation period. Methods: Bilateral electroneurography of the motor and sensory fibers in the median and ulnar nerves, recording compound muscle action potential (CMAP) and sensory nerve action potential (SNAP), was performed twice in 5-, 7-, and 19-year-old males at two time points: before and five years after the application of ERT and HSCT. Results: In three MPS patients with Hurler or Hunter syndrome, ENG studies similarly demonstrated decreased amplitudes and prolonged distal latencies in their CMAP recordings, confirming the bilateral progression of axonal degeneration and demyelinating changes in the distal parts of the median nerves. The SNAP recordings revealed more severe degenerative processes of similar types in the sensory fibers of the median nerves. Nerve conduction studies in the ulnar nerve fibers bilaterally revealed analogous pathologies, but with a lesser degree of progression. Conclusions: This study confirms the progression of axonal degeneration and demyelinating changes in the distal parts of the median nerves, which were associated with decreased amplitudes and prolonged distal latencies in the CMAP recordings of the MPS patients. More expressed degeneration processes of a similar type were found in the sensory fibers of the median nerves. Ulnar nerve pathologies of neural conduction are less advanced in patients with Hurler and Hunter syndromes. It seems advisable to implement neurophysiological diagnostics as soon as possible to specify surgical or conservative therapy, which is crucial for maintaining hand function in the case of progressive peripheral neuropathies in patients with MPS. The timing of the treatment and the patient’s age may be factors influencing the effectiveness of treatment.

## Linked entities

- **Diseases:** mucopolysaccharidosis (MONDO:0019249), Hurler syndrome (MONDO:0001586), Hunter syndrome (MONDO:0010674)

## Full-text entities

- **Genes:** TTR (transthyretin) [NCBI Gene 7276] {aka AMYLD1, ATTR, CTS, CTS1, HEL111, HsT2651}, IDS (iduronate 2-sulfatase) [NCBI Gene 3423] {aka ID2S, MPS2, SIDS}, IDUA (alpha-L-iduronidase) [NCBI Gene 3425] {aka IDA, MPS1, MPSI}
- **Diseases:** sensory loss (MESH:C580162), atlanto-axial instability (MESH:C538196), respiratory system dysfunction (MESH:D015619), aggressiveness (MESH:D010554), Hand deformities (MESH:D006226), Peripheral neuropathy (MESH:D010523), pain syndromes (MESH:C538101), skeletal deformities (MESH:D009140), axonal degeneration (MESH:D009410), scaphocephalic skull (MESH:D012888), carpal tunnel syndrome (MESH:D002349), vertebral and/or rib abnormalities (MESH:C537613), ulnar nerve neuropathy (MESH:D020424), coxa valga (MESH:D060906), median and ulnar nerve neuropathy (MESH:D020423), axonal damage (MESH:D001480), Neuropathy (MESH:D009422), cognitive and mental impairments (MESH:D003072), rigidity of paraspinal ligaments (MESH:D009127), MPSs (MESH:D009083), joint mobility (MESH:D014086), nerve damage (MESH:D000080902), SNAP (MESH:D009207), Death (MESH:D003643), Deficiency (MESH:D007153), intellectual disability (MESH:D008607), demyelinating (MESH:D003711), broad hands (MESH:D006952), joint stiffness (MESH:C535724), intellectual deficiencies (MESH:D001037), joint pain (MESH:D018771), Hunter syndrome (MESH:D016532), Mucopolysaccharidosis of the second type (MESH:D016609), median and ulnar neuropathy (MESH:C563598), fingers (MESH:D005383), impaired muscle strength and motor skills (MESH:D019957), cardiomyopathy (MESH:D009202), dysostosis multiplex (MESH:D004413), Facial dysmorphisms (MESH:C565579), musculoskeletal defects (MESH:D009139), axonal loss (MESH:D012183), Joint contractures (MESH:D003286), bone dysplasia (MESH:D001848), Hyperactivity (MESH:D006948), acetabular dysplasia (OMIM:142700), congenital genetic diseases (MESH:D030342), hearing deficiency (MESH:D034381), neurological deficits (MESH:D009461), short stature (MESH:D006130), compressive neuropathy (MESH:D009408), muscle (MESH:D019042), corneal clouding (MESH:C535990), respiratory tract dysfunction (MESH:D012140), Upper extremity deformities (MESH:D038062), ENG anomalies (MESH:D000013), nervous system abnormalities (MESH:D009421), Atrophy of the APB muscle (MESH:D009133), lipomas (MESH:D008067), inflammation (MESH:D007249), respiratory infections (MESH:D012141)
- **Chemicals:** AMP (MESH:D000249), GAG (MESH:D006025), HS (MESH:D006497), SNAP (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12942878/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12942878/full.md

## References

47 references — full list in the complete paper: https://tomesphere.com/paper/PMC12942878/full.md

---
Source: https://tomesphere.com/paper/PMC12942878